139 related articles for article (PubMed ID: 15268736)
1. Prospective evaluation of the clinical utility of different methods for the detection of human cytomegalovirus disease after liver transplantation.
Seehofer D; Meisel H; Rayes N; Stein A; Langrehr JM; Settmacher U; Neuhaus P
Am J Transplant; 2004 Aug; 4(8):1331-7. PubMed ID: 15268736
[TBL] [Abstract][Full Text] [Related]
2. Detection of human cytomegalovirus (HCMV) pp67-mRNA and pp65 antigenemia in relation to development of clinical HCMV disease in renal transplant recipients.
Degré M; Kristiansen KI; Rollag H; Holter E; Nordal KP
Clin Microbiol Infect; 2001 May; 7(5):254-60. PubMed ID: 11422252
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.
Gerna G; Baldanti F; Middeldorp JM; Furione M; Zavattoni M; Lilleri D; Revello MG
J Clin Microbiol; 1999 Apr; 37(4):902-11. PubMed ID: 10074499
[TBL] [Abstract][Full Text] [Related]
4. Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients.
Gerna G; Baldanti F; Lilleri D; Parea M; Alessandrino E; Pagani A; Locatelli F; Middeldorp J; Revello MG
J Clin Microbiol; 2000 May; 38(5):1845-53. PubMed ID: 10790111
[TBL] [Abstract][Full Text] [Related]
5. Detection of late pp67-mRNA by NASBA in peripheral blood for the diagnosis of human cytomegalovirus disease in AIDS patients.
Blank BS; Meenhorst PL; Pauw W; Mulder JW; van Dijk WC; Smits PH; Roeles F; Middeldorp JM; Lange JM
J Clin Virol; 2002 Jul; 25(1):29-38. PubMed ID: 12126719
[TBL] [Abstract][Full Text] [Related]
6. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection.
Mengoli C; Cusinato R; Biasolo MA; Cesaro S; Parolin C; Palù G
J Med Virol; 2004 Sep; 74(1):78-84. PubMed ID: 15258972
[TBL] [Abstract][Full Text] [Related]
7. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G
J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
[TBL] [Abstract][Full Text] [Related]
8. Relationship between pp65 antigenemia levels and real-time quantitative DNA PCR for Human Cytomegalovirus (HCMV) management in immunocompromised patients.
Cariani E; Pollara CP; Valloncini B; Perandin F; Bonfanti C; Manca N
BMC Infect Dis; 2007 Nov; 7():138. PubMed ID: 18036216
[TBL] [Abstract][Full Text] [Related]
9. Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture.
Boeckh M; Gallez-Hawkins GM; Myerson D; Zaia JA; Bowden RA
Transplantation; 1997 Jul; 64(1):108-13. PubMed ID: 9233710
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients.
Gerna G; Percivalle E; Baldanti F; Sarasini A; Zavattoni M; Furione M; Torsellini M; Revello MG
New Microbiol; 1998 Jul; 21(3):293-308. PubMed ID: 9699213
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of human cytomegalovirus, HHV-6 and HHV-7 infection in kidney transplant recipients by molecular methods to predict HCMV disease after transplantation: a prospective study.
Rayes N; Seehofer D; Lullius SG; Stein A; May G; Kahl A; Frei U; Neuhaus P; Meisel H
Ann Transplant; 2005; 10(2):23-8. PubMed ID: 16218029
[TBL] [Abstract][Full Text] [Related]
12. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation.
Solano C; Muñoz I; Gutiérrez A; Farga A; Prósper F; García-Conde J; Navarro D; Gimeno C
J Clin Microbiol; 2001 Nov; 39(11):3938-41. PubMed ID: 11682510
[TBL] [Abstract][Full Text] [Related]
13. Value of different assays for detection of human cytomegalovirus (HCMV) in predicting the development of HCMV disease in human immunodeficiency virus-infected patients.
Blank BS; Meenhorst PL; Mulder JW; Weverling GJ; Putter H; Pauw W; van Dijk WC; Smits P; Lie-A-Ling S; Reiss P; Lange JM
J Clin Microbiol; 2000 Feb; 38(2):563-9. PubMed ID: 10655346
[TBL] [Abstract][Full Text] [Related]
14. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic implications of human cytomegalovirus immediate early-1 and pp67 mRNA detection in whole-blood samples from liver transplant patients using nucleic acid sequence-based amplification.
Blok MJ; Lautenschlager I; Goossens VJ; Middeldorp JM; Vink C; Höckerstedt K; Bruggeman CA
J Clin Microbiol; 2000 Dec; 38(12):4485-91. PubMed ID: 11101584
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation.
Hebart H; Müller C; Löffler J; Jahn G; Einsele H
Bone Marrow Transplant; 1996 May; 17(5):861-8. PubMed ID: 8733710
[TBL] [Abstract][Full Text] [Related]
17. Use of the human cytomegalovirus (HCMV) antigenemia assay for diagnosis and monitoring of HCMV infections and detection of antiviral drug resistance in the immunocompromised.
Baldanti F; Revello MG; Percivalle E; Gerna G
J Clin Virol; 1998 Jul; 11(1):51-60. PubMed ID: 9784143
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus (CMV) DNA amplification from plasma compared with CMV pp65 antigen (ppUL83) detection in leukocytes for early diagnosis of symptomatic CMV infection in kidney transplant patients.
Wirgart BZ; Claesson K; Eriksson BM; Brundin M; Tufveson G; Tötterman T; Grillner L
Clin Diagn Virol; 1996 Nov; 7(2):99-110. PubMed ID: 9137866
[TBL] [Abstract][Full Text] [Related]
19. Development of a quantitative-competitive PCR for quantification of human cytomegalovirus load and comparison with antigenaemia, viraemia and pp67 RNA detection by nucleic acid sequence-based amplification.
Bergallo M; Costa C; Tarallo S; Daniele R; Merlino C; Segoloni GP; Negro Ponzi A; Cavallo R
Panminerva Med; 2006 Jun; 48(2):119-27. PubMed ID: 16953149
[TBL] [Abstract][Full Text] [Related]
20. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.
Martín-Dávila P; Fortún J; Gutiérrez C; Martí-Belda P; Candelas A; Honrubia A; Barcena R; Martínez A; Puente A; de Vicente E; Moreno S
J Clin Virol; 2005 Jun; 33(2):138-44. PubMed ID: 15911429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]